$NTIC
NORTHERN TECHNOLOGIES INTERNATIONAL CORP Stock $ntic

$ntic Overview Financials Valuation SEC Filings Company Website

2018 Q3 Form 10-K Financial Statement

#000117184319007508 Filed on November 13, 2019

Income Statement

Concept	2018 Q3	2018 Q2	2018 Q1
Revenue	$14.74M	$12.92M	$12.21M
YoY Change	35.23%	26.42%	39.7%
Cost Of Revenue	$9.670M	$8.592M	$8.013M
YoY Change	36.97%	26.84%	36.5%
Gross Profit	$5.070M	$4.331M	$4.201M
YoY Change	32.03%	25.59%	46.24%
Gross Profit Margin	34.4%	33.52%	34.4%
Selling, General & Admin	$5.350M	$4.772M	$4.449M
YoY Change	22.15%	16.02%	8.8%
% of Gross Profit	105.52%	110.18%	105.9%
Research & Development	$940.0K	$860.3K	$922.7K
YoY Change	18.99%	17.27%	24.35%
% of Gross Profit	18.54%	19.86%	21.96%
Depreciation & Amortization	$280.0K	$270.0K	$280.0K
YoY Change	16.67%	22.73%	21.74%
% of Gross Profit	5.52%	6.23%	6.66%
Operating Expenses	$4.770M	$5.633M	$5.372M
YoY Change	30.33%	16.21%	11.19%
Operating Profit	$300.0K	$2.453M	$2.244M
YoY Change	66.67%	41.81%	268.64%
Interest Expense	$1.740M	$3.139K	$5.779K
YoY Change	10.13%	-57.63%	66.54%
% of Operating Profit	580.0%	0.13%	0.26%
Other Income/Expense, Net
YoY Change
Pretax Income	$2.050M	$2.490M	$2.260M
YoY Change	16.48%	43.93%	270.49%
Income Tax	-$190.0K	$181.7K	$841.9K
% Of Pretax Income	-9.27%	7.3%	37.25%
Net Earnings	$2.140M	$2.143M	$1.333M
YoY Change	53.96%	58.44%	244.44%
Net Earnings / Revenue	14.52%	16.58%	10.91%
Basic Earnings Per Share		$0.24	$0.29
Diluted Earnings Per Share	$225.3K	$0.23	$0.29
COMMON SHARES
Basic Shares Outstanding		9.079M	4.537M
Diluted Shares Outstanding		9.414M	4.673M

Balance Sheet

Concept	2018 Q3	2018 Q2	2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.460M	$7.890M	$8.340M
YoY Change	-26.36%	8.68%	119.47%
Cash & Equivalents	$4.163M	$4.610M	$5.067M
Short-Term Investments	$3.300M	$3.280M	$3.270M
Other Short-Term Assets	$1.660M	$1.080M	$1.020M
YoY Change	277.27%	157.14%	67.21%
Inventory	$9.131M	$9.175M	$9.126M
Prepaid Expenses	$1.662M	$1.081M	$1.025M
Receivables	$10.68M	$9.290M	$8.760M
Other Receivables	$1.630M	$1.720M	$1.670M
Total Short-Term Assets	$30.57M	$29.16M	$28.92M
YoY Change	17.26%	18.33%	42.27%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.169M	$7.233M	$7.156M
YoY Change	-2.59%	-2.93%	-4.4%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$22.95M	$22.41M	$22.26M
YoY Change	14.55%	18.56%	5.7%
Other Assets	$153.8K	$153.8K
YoY Change	114.62%	114.61%
Total Long-Term Assets	$25.81M	$24.82M	$24.56M
YoY Change	11.33%	13.31%	2.42%
TOTAL ASSETS
Total Short-Term Assets	$30.57M	$29.16M	$28.92M
Total Long-Term Assets	$25.81M	$24.82M	$24.56M
Total Assets	$63.55M	$61.21M	$60.63M
YoY Change	12.25%	13.36%	17.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.905M	$3.316M	$4.266M
YoY Change	45.89%	-6.8%	19.64%
Accrued Expenses	$3.750M	$2.920M	$2.120M
YoY Change	68.92%	137.4%	51.43%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$7.730M	$6.349M	$6.724M
YoY Change	57.93%	32.53%	35.53%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.730M	$6.349M	$6.724M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$10.47M	$9.390M	$9.630M
YoY Change	35.1%	25.37%	28.4%
SHAREHOLDERS EQUITY
Retained Earnings	$41.96M	$40.28M	$38.59M
YoY Change	13.18%	12.84%	12.37%
Common Stock	$14.71M	$14.61M	$14.49M
YoY Change	3.2%	3.79%	3.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$53.08M	$51.82M	$51.00M
YoY Change
Total Liabilities & Shareholders Equity	$63.55M	$61.21M	$60.63M
YoY Change	12.25%	13.36%	17.07%

Cashflow Statement

Concept	2018 Q3	2018 Q2	2018 Q1
OPERATING ACTIVITIES
Net Income	$2.140M	$2.143M	$1.333M
YoY Change	53.96%	58.44%	244.44%
Depreciation, Depletion And Amortization	$280.0K	$270.0K	$280.0K
YoY Change	16.67%	22.73%	21.74%
Cash From Operating Activities	$750.0K	$380.0K	$910.0K
YoY Change	-74.23%	-89.59%	810.0%
INVESTING ACTIVITIES
Capital Expenditures	-$210.0K	-$310.0K	-$130.0K
YoY Change	10.53%	55.0%	-75.0%
Acquisitions
YoY Change
Other Investing Activities	-$10.00K	-$20.00K	$500.0K
YoY Change	0.0%	-99.34%	-50.0%
Cash From Investing Activities	-$220.0K	-$330.0K	$370.0K
YoY Change	4.76%	-89.72%	-22.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-850.0K	-440.0K	-910.0K
YoY Change	-1162.5%	-4500.0%	1037.5%
NET CHANGE
Cash From Operating Activities	750.0K	380.0K	910.0K
Cash From Investing Activities	-220.0K	-330.0K	370.0K
Cash From Financing Activities	-850.0K	-440.0K	-910.0K
Net Change In Cash	-320.0K	-390.0K	370.0K
YoY Change	-111.51%	-186.67%	-26.0%
FREE CASH FLOW
Cash From Operating Activities	$750.0K	$380.0K	$910.0K
Capital Expenditures	-$210.0K	-$310.0K	-$130.0K
Free Cash Flow	$960.0K	$690.0K	$1.040M
YoY Change	-69.03%	-82.08%	67.74%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2019	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019	dei	Document Period End Date DocumentPeriodEndDate	2019-08-31
CY2019	dei	Amendment Flag AmendmentFlag	false
CY2019	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--08-31
CY2019	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2019	dei	Document Type DocumentType	10-K
CY2019	dei	Entity Central Index Key EntityCentralIndexKey	0000875582
CY2019Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9090413
CY2019	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2019	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2019Q1	dei	Entity Public Float EntityPublicFloat	117600000
CY2019	dei	Entity Registrant Name EntityRegistrantName	Northern Technologies International Corporation
CY2019	dei	Entity Shell Company EntityShellCompany	false
CY2019	dei	Entity Small Business EntitySmallBusiness	true
CY2019	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2019	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2019	dei	Security12b Title Security12bTitle	Common stock, par value $0.02 per share
CY2019	dei	Trading Symbol TradingSymbol	ntic
CY2019	ntic	Allocated Share Based Compensation Expense Estimate Next Fiscal Year AllocatedShareBasedCompensationExpenseEstimateNextFiscalYear	65270
CY2019Q3	ntic	Assets Noncurrent Other Than Property Plant And Equipment AssetsNoncurrentOtherThanPropertyPlantAndEquipment	26850566
CY2018Q3	ntic	Assets Noncurrent Other Than Property Plant And Equipment AssetsNoncurrentOtherThanPropertyPlantAndEquipment	25812637
CY2019Q3	ntic	Deferred Tax Assets Operating Loss Carryforwards Domestic State And Local DeferredTaxAssetsOperatingLossCarryforwardsDomesticStateAndLocal	532000
CY2019	ntic	Defined Contribution Plan Maximum Amount Of Employees Contributions Percent DefinedContributionPlanMaximumAmountOfEmployeesContributionsPercent	0.5
CY2019Q3	ntic	Entity Wide Trade Joint Venture Receivables Three Joint Ventures Percentage EntityWideTradeJointVentureReceivablesThreeJointVenturesPercentage	0.696
CY2018Q3	ntic	Entity Wide Trade Joint Venture Receivables Three Joint Ventures Percentage EntityWideTradeJointVentureReceivablesThreeJointVenturesPercentage	0.741
CY2019	ntic	Fees For Services Provided To Joint Ventures FeesForServicesProvidedToJointVentures	5727579
CY2018	ntic	Fees For Services Provided To Joint Ventures FeesForServicesProvidedToJointVentures	6142139
CY2019Q3	ntic	Fees Receivable For Services Provided To Joint Ventures Current FeesReceivableForServicesProvidedToJointVenturesCurrent	1268000
CY2018Q3	ntic	Fees Receivable For Services Provided To Joint Ventures Current FeesReceivableForServicesProvidedToJointVenturesCurrent	1357255
CY2019	ntic	Foreign Withholding Tax ForeignWithholdingTax	4000
CY2018	ntic	Foreign Withholding Tax ForeignWithholdingTax	79000
CY2019	ntic	Increase Decrease In Fees Receivable For Services Provided To Joint Ventures IncreaseDecreaseInFeesReceivableForServicesProvidedToJointVentures	-89255
CY2018	ntic	Increase Decrease In Fees Receivable For Services Provided To Joint Ventures IncreaseDecreaseInFeesReceivableForServicesProvidedToJointVentures	54311
CY2019	ntic	Increase Decrease In Trade Receivables Excluding Joint Ventures IncreaseDecreaseInTradeReceivablesExcludingJointVentures	50315
CY2018	ntic	Increase Decrease In Trade Receivables Excluding Joint Ventures IncreaseDecreaseInTradeReceivablesExcludingJointVentures	4372619
CY2019	ntic	Increase Decrease In Trade Receivables Joint Ventures IncreaseDecreaseInTradeReceivablesJointVentures	62967
CY2018	ntic	Increase Decrease In Trade Receivables Joint Ventures IncreaseDecreaseInTradeReceivablesJointVentures	69754
CY2019	ntic	Net Sales Excluding Joint Ventures NetSalesExcludingJointVentures	53142583
CY2018	ntic	Net Sales Excluding Joint Ventures NetSalesExcludingJointVentures	48516749
CY2019	ntic	Net Sales To Joint Ventures NetSalesToJointVentures	2607554
CY2018	ntic	Net Sales To Joint Ventures NetSalesToJointVentures	2908072
CY2018Q3	ntic	Trade Receivables Excluding Joint Ventures Net Current TradeReceivablesExcludingJointVenturesNetCurrent	9920108
CY2018	ntic	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercises In Period Including Cashless Exercises SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisesInPeriodIncludingCashlessExercises	12814
CY2019	ntic	Total Fees For Services Provided To Joint Ventures Geographic Location TotalFeesForServicesProvidedToJointVenturesGeographicLocation	5727579
CY2018	ntic	Total Fees For Services Provided To Joint Ventures Geographic Location TotalFeesForServicesProvidedToJointVenturesGeographicLocation	6142139
CY2019Q3	ntic	Trade Receivables Excluding Joint Ventures Net Current TradeReceivablesExcludingJointVenturesNetCurrent	9779518
CY2019Q3	ntic	Trade Receivables Joint Ventures Current TradeReceivablesJointVenturesCurrent	824473
CY2018Q3	ntic	Trade Receivables Joint Ventures Current TradeReceivablesJointVenturesCurrent	761506
CY2019	ntic	Unrecognized Tax Benefits Increase Decrease Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions	1000
CY2018	ntic	Unrecognized Tax Benefits Increase Decrease Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions	-12000
CY2019Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	4505531
CY2018Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	3905034
CY2019Q3	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	1200000
CY2018Q3	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	2153000
CY2019Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	6759
CY2018Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	70892
CY2019Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5605850
CY2018Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4749095
CY2019Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4593178
CY2018Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3597199
CY2019Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	16013338
CY2018Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	14528951
CY2019	us-gaap	Adjustment For Amortization AdjustmentForAmortization	261724
CY2018	us-gaap	Adjustment For Amortization AdjustmentForAmortization	252312
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	413010
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	1431925
CY2019Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	65000
CY2018Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	50000
CY2019Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	65000
CY2018Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	50000
CY2019Q3	us-gaap	Assets Assets	67511087
CY2018Q3	us-gaap	Assets Assets	63549236
CY2019Q3	us-gaap	Assets Current AssetsCurrent	33302362
CY2018Q3	us-gaap	Assets Current AssetsCurrent	30567773
CY2019Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	3565258
CY2018Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	3300110
CY2019Q3	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	3565258
CY2018Q3	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	3300110
CY2019Q3	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	7749980
CY2018Q3	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	6927484
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	53512
CY2018	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4163023
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6360201
CY2019Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5856758
CY2019	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1693735
CY2018	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2197178
CY2019Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2018Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.24
CY2018	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.20
CY2018Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.06
CY2019Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.06
CY2019Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.06
CY2019Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.06
CY2017Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.05
CY2018Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.05
CY2018Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.05
CY2018Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.05
CY2019Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.02
CY2018Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.02
CY2019Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	10683900
CY2018Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	10477300
CY2019Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	15000000
CY2018Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	15000000
CY2019Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9086816
CY2018Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9082606
CY2019Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9086816
CY2018Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9082606
CY2019Q3	us-gaap	Common Stock Value CommonStockValue	181736
CY2018Q3	us-gaap	Common Stock Value CommonStockValue	181652
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4213643
CY2018	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5575231
CY2019	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	598336
CY2018	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	484861
CY2019	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	4811979
CY2018	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	6060092
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	37970244
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	34165440
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	902000
CY2018	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	671000
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	950000
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	672000
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	48000
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1000
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-315000
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	477000
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	228000
CY2018	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-297000
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-108000
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	204000
CY2019Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	265300
CY2018Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	270800
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-21000
CY2018	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	24000
CY2019Q3	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	688400
CY2018Q3	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	695800
CY2019Q3	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	60900
CY2018Q3	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	58900
CY2019Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1634300
CY2018Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1552000
CY2019Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1899600
CY2018Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1822800
CY2019Q3	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	1634258
CY2018Q3	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	1551536
CY2019Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	152000
CY2019Q3	us-gaap	Deferred Tax Assets Other Tax Carryforwards DeferredTaxAssetsOtherTaxCarryforwards	3631700
CY2018Q3	us-gaap	Deferred Tax Assets Other Tax Carryforwards DeferredTaxAssetsOtherTaxCarryforwards	3241200
CY2019Q3	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Foreign DeferredTaxAssetsTaxCreditCarryforwardsForeign	5790500
CY2018Q3	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Foreign DeferredTaxAssetsTaxCreditCarryforwardsForeign	5789600
CY2019Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	153400
CY2018Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	430600
CY2019Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	299300
CY2018Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	197500
CY2019Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	39700
CY2018Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	63700
CY2019Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	8764300
CY2018Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	8654500
CY2019Q3	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	153400
CY2018Q3	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	146200
CY2019Q3	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	111900
CY2018Q3	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	124600
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	228605
CY2018	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	219379
CY2019	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.035
CY2019	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.15
CY2019	us-gaap	Depreciation Depreciation	841236
CY2018	us-gaap	Depreciation Depreciation	853555
CY2019	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div>       ACCOUNTING PRONOUNCEMENTS</div></div> <div style=" font-size: 10pt; margin: 0pt 0"> </div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-style: italic;">New Accounting Pronouncements Adopted</div></div> <div style=" font-size: 10pt; margin: 0pt 0"> </div> <div style=" font-size: 10pt; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2014, </div>the Financial Accounting Standards Board (FASB) issued guidance creating Accounting Standards Codification (ASC) Section <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606,</div> <div style="display: inline; font-style: italic;">Revenue from Contracts with Customers</div> (ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div>), which establishes a comprehensive new model for the recognition of revenue from contracts with customers. This model is based on the core principle that revenue should be recognized to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.</div> <div style=" font-size: 10pt; margin: 0pt 0"> </div> <div style=" font-size: 10pt; margin: 0pt 0">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 1, 2018, </div>the Company adopted ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div> for all customer contracts using the modified retrospective method. To determine revenue recognition for arrangements within the scope of ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606,</div> the Company performs the following <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> steps: (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div>) identify the contracts with a customer; (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div>) identify the performance obligations in the contract; (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div>) determine the transaction price; (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div>) allocate the transaction price to the performance obligations in the contract; and (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div>) recognize revenue when or as the entity satisfies a performance obligation. The Company only applies the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div>-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods it transfers to, or services it performs for, the customer.</div> <div style=" font-size: 10pt; margin: 0pt 0"></div> <!-- Field: /Page --> <div style=" font-size: 10pt; margin: 0pt 0"> </div> <div style=" font-size: 10pt; margin: 0pt 0">The adoption of ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div> neither impacted the previously reported financial statements in any prior period nor did it result in a cumulative effect adjustment to retained earnings. Therefore, the adoption of the standard did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> impact the Company’s revenue recognition process. Generally, the Company’s performance obligations are satisfied when the customers take possession of the products, which normally occurs at the shipping point or destination depending on the terms of the contracts. The Company’s services are generally sold based upon quotes or contracts with customers that include a fixed or determinable price, and sales arrangements do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> contain any significant financing component for its customers. The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> recognize revenue related to product warranties, nor does the Company incur significant contract costs. Customer arrangements do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> generate contract assets or liabilities.</div> <div style=" font-size: 10pt; margin: 0pt 0"> </div> <div style=" font-size: 10pt; margin: 0pt 0">The Company applies the practical expedient in paragraph <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14</div> and does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> disclose information about remaining performance obligations that have original expected durations of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year or less. There are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> material obligations that extend beyond <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year. Revenue is recognized when transfer of control occurs as defined by the terms in the customer agreement. The Company immediately recognizes incidental items that are immaterial in the context of the contract. The Company has applied the practical expedient in paragraph <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16A</div> and does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> assess if immaterial items are promised goods or services. The Company has also applied the practical expedient in paragraph <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">32</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18</div> regarding the adjustment of the promised amount of consideration for the effects of a significant financing component when the customer pays for that good or service within <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year or less, as the Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have any significant financing components in its customer arrangements since payment is received at or shortly after the point of sale, generally <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">thirty</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">ninety</div> days.</div> <div style=" font-size: 10pt; margin: 0pt 0"></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-style: italic;"> </div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-style: italic;">Recently Issued Accounting Pronouncements</div></div> <div style=" font-size: 10pt; margin: 0pt 0"> </div> <div style=" font-size: 10pt; margin: 0pt 0">During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2016, </div>the FASB issued Accounting Standards Update (ASU) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> <div style="display: inline; font-style: italic;">Leases</div>. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> was issued to increase transparency and comparability among organizations by recognizing all lease transactions (with terms in excess of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12</div> months) on the balance sheet as a lease liability and a right-of-use asset (as defined). The Company will adopt this ASU for its annual and interim periods beginning <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 1, 2019, </div>and elected <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> to restate comparative periods in transition. The Company performed a review of the</div> <div style=" font-size: 10pt; margin: 0pt 0">requirements of the new guidance and identified which of its leases will be within the scope of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02.</div> The Company completed its adoption plan, which included a review of lease contracts, applying the new standard to the lease contracts and comparing the results to our current accounting. Effective for our quarter ending <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 30, 2019, </div>the Company will revise its lease accounting policy disclosures to reflect the requirements of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02.</div> The Company estimates the impact of the adoption will be an increase in the range of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$500,000</div></div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$750,000</div></div> to both assets and liabilities on the consolidated balance sheet. The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> believe the adoption of this guidance will have a material impact on its consolidated results of operations or cash flows. The Company also expects additional qualitative and quantitative disclosures will be required upon adoption.</div> <div style=" font-size: 10pt; margin: 0pt 0"> </div> <div style=" font-size: 10pt; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2018, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> <div style="display: inline; font-style: italic;">Income Statement – Reporting Comprehensive Income (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">220</div>) Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income</div>, which will allow a reclassification from accumulated other comprehensive income to retained earnings for the tax effects resulting from the Tax Reform Act that are stranded in accumulated other comprehensive income. This standard also requires certain disclosures about stranded tax effects. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> however, does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> change the underlying guidance that requires that the effect of a change in tax laws or rates be included in income from continuing operations. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> will be effective for the Company’s fiscal year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2020,</div> with the option for early adoption at any time prior to the effective date. It must be applied either in the period of adoption or retrospectively to each period in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Reform Act is recognized. The Company is currently assessing the impact this new accounting guidance will have on its consolidated financial statements.</div> <div style=" font-size: 10pt; margin: 0pt 0"></div> <!-- Field: /Page --> <div style=" font-size: 10pt; margin: 0pt 0"> </div> <div style=" font-size: 10pt; margin: 0pt 0">Although there are several other new accounting pronouncements issued or proposed by the FASB, which the Company has adopted or will adopt, as applicable, the Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> believe any of these accounting pronouncements has had or will have a material impact on the Company’s consolidated financial position or operating results.</div></div>
CY2018Q4	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2018-11-21
CY2019Q1	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2019-02-22
CY2019Q2	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2019-05-23
CY2019Q3	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2019-08-21
CY2017Q4	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2017-12-21
CY2018Q1	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2018-02-21
CY2018Q2	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2018-05-23
CY2018Q3	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2018-08-22
CY2018	us-gaap	Dividends Dividends	1815508
CY2019	us-gaap	Dividends Dividends	2180244
CY2018Q4	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2018-11-07
CY2019Q1	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2019-02-06
CY2019Q2	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2019-05-09
CY2019Q3	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2019-08-07
CY2017Q4	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2017-12-08
CY2018Q1	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2018-02-07
CY2018Q2	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2018-05-09
CY2018Q3	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2018-08-08
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.57
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.55
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.74
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.72
CY2019	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-49702
CY2018	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-133632
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.257
CY2019Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1857971
CY2018Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2747303
CY2019	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	5039041
CY2018	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	3697503
CY2019Q3	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	63326703
CY2018Q3	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	62803261
CY2019Q3	us-gaap	Equity Method Investment Summarized Financial Information Current Assets EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets	59162834
CY2018Q3	us-gaap	Equity Method Investment Summarized Financial Information Current Assets EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets	58086747
CY2019Q3	us-gaap	Equity Method Investment Summarized Financial Information Current Liabilities EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities	14145499
CY2018Q3	us-gaap	Equity Method Investment Summarized Financial Information Current Liabilities EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities	15991886
CY2019Q3	us-gaap	Equity Method Investment Summarized Financial Information Equity EquityMethodInvestmentSummarizedFinancialInformationEquity	49160407
CY2018Q3	us-gaap	Equity Method Investment Summarized Financial Information Equity EquityMethodInvestmentSummarizedFinancialInformationEquity	46407722
CY2019	us-gaap	Equity Method Investment Summarized Financial Information Gross Profit Loss EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss	51312013
CY2018	us-gaap	Equity Method Investment Summarized Financial Information Gross Profit Loss EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss	53348459
CY2019	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	14688999
CY2018	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	15300276
CY2019Q3	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Liabilities EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities	20797
CY2018Q3	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Liabilities EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities	403653
CY2019	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	114635435
CY2018	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	120060897
CY2019Q3	us-gaap	Equity Method Investment Underlying Equity In Net Assets EquityMethodInvestmentUnderlyingEquityInNetAssets	24207339
CY2018Q3	us-gaap	Equity Method Investment Underlying Equity In Net Assets EquityMethodInvestmentUnderlyingEquityInNetAssets	22950995
CY2019Q3	us-gaap	Equity Method Investments EquityMethodInvestments	24207339
CY2018Q3	us-gaap	Equity Method Investments EquityMethodInvestments	22950995
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	133000
CY2018	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-173000
CY2019Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1008969
CY2018Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1156257
CY2019	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	36098
CY2018	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	10723
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9349559
CY2018	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8500490
CY2019	us-gaap	Gross Profit GrossProfit	17779893
CY2018	us-gaap	Gross Profit GrossProfit	17259381
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	7225518
CY2018	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	7527383
CY2019	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	6657459
CY2018	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	8098950
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	841837
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	876103
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	208000
CY2018	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	57000
CY2019	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-103000
CY2018	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-60000
CY2019	us-gaap	Income Tax Reconciliation Repatriation Of Foreign Earnings IncomeTaxReconciliationRepatriationOfForeignEarnings	204000
CY2018	us-gaap	Income Tax Reconciliation Repatriation Of Foreign Earnings IncomeTaxReconciliationRepatriationOfForeignEarnings	4011000
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	27000
CY2018	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	25000
CY2019	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	133000
CY2019	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate
CY2018	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	633000
CY2019	us-gaap	Income Tax Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	1490000
CY2018	us-gaap	Income Tax Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	1903000
CY2019	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	672000
CY2018	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	101000
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1398000
CY2018	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	2081000
CY2019	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	74000
CY2018	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	103000
CY2018	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	10000
CY2019	us-gaap	Income Tax Reconciliation Tax Credits Foreign IncomeTaxReconciliationTaxCreditsForeign
CY2018	us-gaap	Income Tax Reconciliation Tax Credits Foreign IncomeTaxReconciliationTaxCreditsForeign	3783000
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	841837
CY2018	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	876103
CY2019Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	457018
CY2018Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	273333
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	682786
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1641132
CY2019	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-65344
CY2018	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	73546
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-222952
CY2018	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1720376
CY2019	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	89637
CY2018	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-186808
CY2019	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	189226
CY2018	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	191090
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1486833
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1909253
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-744323
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1317269
CY2019	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	330390
CY2018	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	292728
CY2019Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	8507912
CY2019	us-gaap	Interest Expense InterestExpense	13567
CY2018	us-gaap	Interest Expense InterestExpense	17962
CY2019	us-gaap	Interest Paid Net InterestPaidNet	13567
CY2018	us-gaap	Interest Paid Net InterestPaidNet	17962
CY2018Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	7306372
CY2019Q3	us-gaap	Inventory Gross InventoryGross	10488728
CY2018Q3	us-gaap	Inventory Gross InventoryGross	9130861
CY2019Q3	us-gaap	Inventory Net InventoryNet	10488728
CY2018Q3	us-gaap	Inventory Net InventoryNet	9130861
CY2019Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1980816
CY2018Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1824489
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	78257
CY2018	us-gaap	Investment Income Interest InvestmentIncomeInterest	99463
CY2019Q3	us-gaap	Land Land	310365
CY2018Q3	us-gaap	Land Land	310365
CY2019Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	67511087
CY2018Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	63549236
CY2019Q3	us-gaap	Liabilities Current LiabilitiesCurrent	7841793
CY2018Q3	us-gaap	Liabilities Current LiabilitiesCurrent	7730182
CY2019Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	4903664
CY2018Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	4680072
CY2019Q3	us-gaap	Minority Interest MinorityInterest	3074679
CY2018Q3	us-gaap	Minority Interest MinorityInterest	2742309
CY2018	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	600000
CY2019	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	400000
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2393664
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2372124
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1339921
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-300109
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5477022
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	608687
CY2019	us-gaap	Net Income Loss NetIncomeLoss	5209622
CY2018	us-gaap	Net Income Loss NetIncomeLoss	6701366
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	606000
CY2018	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	521481
CY2019	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	134034
CY2019Q3	us-gaap	Noncurrent Assets NoncurrentAssets	7358159
CY2018Q3	us-gaap	Noncurrent Assets NoncurrentAssets	7168826
CY2019Q3	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	60
CY2019	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
CY2019	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2019	us-gaap	Operating Expenses OperatingExpenses	24140221
CY2018	us-gaap	Operating Expenses OperatingExpenses	22911454
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	6592769
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	8017449
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	635280
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	286723
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	107522
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	241035
CY2019Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1471532
CY2018Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1006953
CY2019Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent
CY2018Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	153849
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1003643
CY2018	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1162755
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1162755
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1003643
CY2019	us-gaap	Other Operating Income OtherOperatingIncome	12953097
CY2018	us-gaap	Other Operating Income OtherOperatingIncome	13669522
CY2019	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2180244
CY2018	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1815508
CY2019	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	400000
CY2018	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	600000
CY2018	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	1518596
CY2019	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	3365146
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	114436
CY2018	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	86481
CY2019	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	0
CY2018	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	0
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	960339
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	680502
CY2019Q3	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2018Q3	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2019Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000
CY2018Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000
CY2019Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2018Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2019Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2018Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2019Q3	us-gaap	Preferred Stock Value PreferredStockValue
CY2018Q3	us-gaap	Preferred Stock Value PreferredStockValue
CY2019Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1062609
CY2018Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1661577
CY2019	us-gaap	Proceeds From Dividends Received ProceedsFromDividendsReceived	5039041
CY2018	us-gaap	Proceeds From Dividends Received ProceedsFromDividendsReceived	3697503
CY2019	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	134034
CY2018	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders
CY2019	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	3100000
CY2018	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	1985470
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	15433
CY2019	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	52546
CY2018	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	27951
CY2019	us-gaap	Profit Loss ProfitLoss	5815622
CY2018	us-gaap	Profit Loss ProfitLoss	7222847
CY2019Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12964009
CY2018Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11917921
CY2019Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7358159
CY2018Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7168826
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3822070
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3524953
CY2019Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	44992719
CY2018Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	41963341
CY2019Q3	us-gaap	Retained Earnings Undistributed Earnings From Equity Method Investees RetainedEarningsUndistributedEarningsFromEquityMethodInvestees	22178126
CY2018Q3	us-gaap	Retained Earnings Undistributed Earnings From Equity Method Investees RetainedEarningsUndistributedEarningsFromEquityMethodInvestees	20921783
CY2019	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-style: italic;">Net Sales </div>– The Company includes net sales to its joint ventures and net sales to unaffiliated customers as separate line items on its consolidated statements of operations. There are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> sales originating from the Company’s joint ventures included in the amount, as the Company’s investments in its joint ventures are accounted for using the equity method.</div> <div style=" font-size: 10pt; margin: 0pt 0"> </div> <div style=" font-size: 10pt; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2014, </div>the Financial Accounting Standards Board (FASB) issued guidance creating Accounting Standards Codification (ASC) Section <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606,</div> <div style="display: inline; font-style: italic;">Revenue from Contracts with Customers</div> (ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div>), which establishes a comprehensive new model for the recognition of revenue from contracts with customers. This model is based on the core principle that revenue should be recognized to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.</div> <div style=" font-size: 10pt; margin: 0pt 0"> </div> <div style=" font-size: 10pt; margin: 0pt 0">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 1, 2018, </div>the Company adopted ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div> for all customer contracts using the modified retrospective method. To determine revenue recognition for arrangements within the scope of ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606,</div> the Company performs the following <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> steps: (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div>) identify the contracts with a customer; (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div>) identify the performance obligations in the contract; (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div>) determine the transaction price; (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div>) allocate the transaction price to the performance obligations in the contract; and (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div>) recognize revenue when or as the entity satisfies a performance obligation. The Company only applies the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div>-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods it transfers to, or services it performs for, the customer.</div> <div style=" font-size: 10pt; margin: 0pt 0"> </div> <div style=" font-size: 10pt; margin: 0pt 0">The adoption of ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div> neither impacted the previously reported financial statements in any prior period nor did it result in a cumulative effect adjustment to retained earnings. Therefore, the adoption of the standard did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> impact the Company’s revenue recognition process. Generally, the Company’s performance obligations are satisfied when the customers take possession of the products, which normally occurs at the shipping point or destination depending on the terms of the contracts. The Company’s services are generally sold based upon quotes or contracts with customers that include a fixed or determinable price, and sales arrangements do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> contain any significant financing component for its customers. The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> recognize revenue related to product warranties, nor does the Company incur significant contract costs. Customer arrangements do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> generate contract assets or liabilities.</div> <div style=" font-size: 10pt; margin: 0pt 0"> </div> <div style=" font-size: 10pt; margin: 0pt 0">Changes to the Company’s significant accounting policies as a result of adopting ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div> are discussed below.</div> <div style=" font-size: 10pt; margin: 0pt 0"> </div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-style: italic;">Revenue Recognition</div> - Revenue is measured based on consideration specified in the contract with a customer, adjusted for any applicable estimates of variable consideration and other factors affecting the transaction price, including noncash consideration, consideration paid or payable to customers, and significant financing components. While most of the Company’s revenue is contracted with customers through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div>-time purchase orders and short-term contracts, the Company does have long-term arrangements with certain customers. Revenue from all customers is recognized when a performance obligation is satisfied by transferring control of a distinct good or service to a customer.</div> <div style=" font-size: 10pt; margin: 0pt 0"> </div> <div style=" font-size: 10pt; margin: 0pt 0">Individually promised goods and services in a contract are considered a distinct performance obligation and accounted for separately if the customer can benefit from the individual good or service on its own or with other resources that are readily available to the customer and the good or service is separately identifiable from other promises in the arrangement. When an arrangement includes multiple performance obligations, the consideration is allocated between the performance obligations in proportion to their estimated standalone selling price. Costs related to products delivered are recognized in the period incurred, unless criteria for capitalization of costs are met. Costs of revenues consist primarily of direct labor, manufacturing overhead, materials, and components. The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> incur significant upfront costs to obtain a contract. If costs to obtain a contract were to become material, the costs would be recorded as an asset and amortized to expense in a manner consistent with the related recognition of revenue.</div> <div style=" font-size: 10pt; margin: 0pt 0"> </div> <div style=" font-size: 10pt; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 68; Value: 1 --> <div style=" font-size: 10pt; margin: 0pt 0"></div> <div style=" font-size: 10pt; margin: 0pt 0">The Company excludes government assessed and imposed taxes on revenue generating transactions that are invoiced to customers from revenue. The Company includes freight billed to customers in revenue. Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as a fulfillment cost and are included in cost of goods sold.</div> <div style=" font-size: 10pt; margin: 0pt 0"> </div> <div style=" font-size: 10pt; margin: 0pt 0">The timing of revenue recognition, billing, and cash collections results in accounts receivable on the balance sheet.</div> <div style=" font-size: 10pt; margin: 0pt 0"> </div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-style: italic;">Performance Obligations</div> - A performance obligation is a promise in a contract to transfer a distinct good or service to the customer. A contract’s transaction price is allocated to each distinct performance obligation in proportion to its standalone selling price and recognized as revenue when, or as, the performance obligation is satisfied. The Company’s various performance obligations and the timing or method of revenue recognition are discussed below.</div> <div style=" font-size: 10pt; margin: 0pt 0"> </div> <div style=" font-size: 10pt; margin: 0pt 0">The Company sells its products to both distributors and end-users. Each unit of product delivered under a customer order represents a distinct and separate performance obligation, as the customer can benefit from each unit on its own or with other resources that are readily available to the customer, and each unit of product is separately identifiable from other products in the arrangement.</div> <div style=" font-size: 10pt; margin: 0pt 0"> </div> <div style=" font-size: 10pt; margin: 0pt 0">The transaction price for the Company’s products is the invoiced amount. The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have variable consideration in the form of refunds, credits, rebates, price concessions, pricing incentives, or other items impacting transaction price. The purchase order pricing in arrangements with customers is deemed to approximate standalone selling price; therefore, the Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> need to allocate proceeds on a relative standalone selling price allocation between performance obligations. The Company applies the practical expedient in paragraph <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14</div> and does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> disclose information about remaining performance obligations that have original expected durations of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year or less. There are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> material obligations that extend beyond <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year.</div> <div style=" font-size: 10pt; margin: 0pt 0"> </div> <div style=" font-size: 10pt; margin: 0pt 0">Revenue is recognized when transfer of control occurs, as defined by the terms in the customer agreement. The Company immediately recognizes incidental items that are immaterial in the context of the contract. The Company has applied the practical expedient in paragraph <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16A</div> and does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> assess if immaterial items are promised goods or services. The Company has also applied the practical expedient in paragraph <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">32</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18</div> regarding the adjustment of the promised amount of consideration for the effects of a significant financing component when the customer pays for that good or service within <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year or less, as the Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have any significant financing components in its customer arrangements since payment is received at or shortly after the point of sale, generally <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">thirty</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">ninety</div> days.</div> <div style=" font-size: 10pt; margin: 0pt 0"> </div> <div style=" font-size: 10pt; margin: 0pt 0">The Company estimates returns based on an analysis of historical experience if the right to return products is granted to its customers. The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> record a return asset, as non-conforming products are generally <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> returned. The Company’s return policy does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> vary by geography. The customer has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> rotation or price protection rights, and the Company is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> under a warranty obligation.</div> <div style=" font-size: 10pt; margin: 0pt 0"> </div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-style: italic;">Sales Commissions</div> - Sales commissions paid to sales representatives are eligible for capitalization, as they are incremental costs that would <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have been incurred without entering into a specific sales arrangement and are recoverable through the expected margin on the transaction. The Company has elected to apply the practical expedient provided by ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">340</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">40</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div> and recognize the incremental costs of obtaining contracts as an expense when incurred, as the amortization period of the assets that would have otherwise been recognized is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year or less. The Company records these costs as a selling expense.</div> <div style=" font-size: 10pt; margin: 0pt 0"> </div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-style: italic;">Product Warranty</div> - The Company offers warranties on various products and services. These warranties are assurance type warranties that are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> sold on a standalone basis; therefore, they are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> considered distinct performance obligations. The Company estimates the costs that <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be incurred under its warranties and records a liability in the amount of such costs at the time the revenue is recognized for the product sale.</div> <div style=" font-size: 10pt; margin: 0pt 0"> </div> <div style=" font-size: 10pt; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 69; Value: 1 --> <div style=" font-size: 10pt; margin: 0pt 0"></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-style: italic;">International Revenue</div> - The Company markets its products to numerous countries in North America, Europe, Latin America, Asia, and other parts of the world. See Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,</div> Segment and Geographical Information, for information regarding revenue disaggregation by geography.</div></div></div></div></div></div></div></div></div></div></div>
CY2019	us-gaap	Revenues Revenues	55750137
CY2018	us-gaap	Revenues Revenues	51424821
CY2019	us-gaap	Selling Expense SellingExpense	10968592
CY2018	us-gaap	Selling Expense SellingExpense	10886011
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	1431925
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	413010
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0132
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0218
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.458
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.459
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0275
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.97
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.29
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.13
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.80
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	9.18
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	18.23
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0187
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	640617
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	7.20
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	94504
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	141767
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	9.02
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.88
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2610422
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	615716
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	697406
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	839173
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2019Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	2403847
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y328D
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y21D
CY2019Q1	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	2462
CY2018Q1	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	1970
CY2018Q3	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	1748
CY2017Q3	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	1780
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2018	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	8820
CY2018	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	27951
CY2019	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	52546
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	15433
CY2019	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	1431925
CY2018	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	413010
CY2015Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	3000000
CY2019Q3	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	2640548
CY2019	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	0
CY2018	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	0
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	56594615
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	53076745
CY2019Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	59669294
CY2018Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	55819054
CY2017Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	51718076
CY2019Q2	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	2
CY2019Q2	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	2
CY2018Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	242000
CY2017Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	250000
CY2019Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	248000
CY2019Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	5000
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	4000
CY2019	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt">Use of Estimates</div> – The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div></div></div></div></div></div></div></div></div>
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9415974
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9370404
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9085584
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9077676

Files In Submission

Name	View Source	Status
0001171843-19-007508-index-headers.html	Edgar Link	pending
0001171843-19-007508-index.html	Edgar Link	pending
0001171843-19-007508.txt	Edgar Link	pending
0001171843-19-007508-xbrl.zip	Edgar Link	pending
exh_211.htm	Edgar Link	pending
exh_231.htm	Edgar Link	pending
exh_311.htm	Edgar Link	pending
exh_312.htm	Edgar Link	pending
exh_321.htm	Edgar Link	pending
exh_322.htm	Edgar Link	pending
exh_42.htm	Edgar Link	pending
f10k_111319p.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
lynch.jpg	Edgar Link	pending
lynch3.jpg	Edgar Link	pending
lynch_sig.jpg	Edgar Link	pending
ntic-20190831.xml	Edgar Link	completed
ntic-20190831.xsd	Edgar Link	pending
ntic-20190831_cal.xml	Edgar Link	unprocessable
ntic-20190831_def.xml	Edgar Link	unprocessable
ntic-20190831_lab.xml	Edgar Link	unprocessable
ntic-20190831_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
wolsfeld.jpg	Edgar Link	pending
wolsfeld3.jpg	Edgar Link	pending
wolsfeld_sig.jpg	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NTIC
NORTHERN TECHNOLOGIES INTERNATIONAL CORP Stock $ntic

2018 Q3 Form 10-K Financial Statement

#000117184319007508 Filed on November 13, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NTIC NORTHERN TECHNOLOGIES INTERNATIONAL CORP Stock $ntic

2018 Q3 Form 10-K Financial Statement

#000117184319007508 Filed on November 13, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NTIC
NORTHERN TECHNOLOGIES INTERNATIONAL CORP Stock $ntic